QUARKBIO
LIVE

Serial Number

87355456

Owner

QUARK BIOSCIENCES TAIWAN, INC.

Attorney

Chinhwei Chen

First Use Date

Jul 31, 2015

Filing Date

Mar 2, 2017

Add to watchlist:

No watchlists yet
View on USPTO

QUARKBIO Trademark

Serial Number: 87355456 • Registration: 5692338

QUARKBIO is a trademark filed by QUARK BIOSCIENCES TAIWAN, INC. on March 2, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

QUARK BIOSCIENCES TAIWAN, INC. (3 trademarks)

4F.-1, NO.6-2, SEC. 2, SHENGYI RD.
ZHUBEI CITY, HSINCHU 30261 , TW

Entity Type: 03

QUARK BIOSCIENCES, INC. (2 trademarks)

4F.-1, NO.6-2, SEC. 2, Shengyi Rd.
Zhubie City, Hsinchu 30261 , TW

Entity Type: 03

Trademark Details

Filing Date

March 2, 2017

Registration Date

March 5, 2019

First Use Anywhere

July 31, 2015

First Use in Commerce

July 31, 2017

Published for Opposition

November 21, 2017

Goods & Services

Apparatus detecting the amount of DNA binding fluorescence dye or the amount of fluorescence dye released from DNA binding probe for laboratory or research use; computer software and hardware for medical diagnostic instrument for real-time PCR instrument, digital PCR instrument; computer software and hardware for processing diagnostic medical testing or laboratory data; hardware and software for use in laboratory management, namely, database management, experimental data management, information management; computer hardware and software for use in laboratory information management; computer software and hardware for data analysis for use in laboratories; computer software and hardware for identifying and analyzing characteristics of nucleic acid sequence and nucleic acid; computer software and hardware for use in gene analysis, human identification, microbial identification in the field of life science research and biological technology development; laboratory apparatus and instruments for gene analysis, human identification, microbial identification in the field of life science research and biological technology development; laboratory apparatus and instruments, namely, spectrophotometer and PCR machine for measuring relative DNA, RNA and protein for research in the field of science, medical treatment and genetics; laboratory equipment for use in the field of medical diagnostics, namely, laboratory test and collection kits comprised of multiplex slide plate, microarrays, pipette racks used for vitro diagnostics; laboratory apparatus for use in gene classification, gene performance analysis, and molecule imaging; laboratory apparatus for genotyping, gene expression analysis, molecular imaging, and nucleic acid sequence analysis; plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; scientific apparatuses, instruments and devices, as well as their parts and components, namely, PCR plates, covers for PCR plates, laboratory test tubes and tissue culture plates, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; computer software for use in database management and electronic storage of data for scientific and medical research; computer software for scientific analysis of nucleic acids; laboratory device, namely, biochips for the identification and detection of biological material from a sample; biochemical analyzers for use with biological microarrays, namely, diagnostic detection unit comprised of an assay, microplate and multiplex slide plate reader, analysis software and database management software for use in biopharmaceutical research; bio-chips for research or scientific purposes; DNA microarrays; DNA chips; laboratory equipment, namely, microarrays; gene analysis equipment, namely, DNA microarrays, DNA microarray scanners, DNA hybridization chambers, and associated software for analyzing genes; laboratory apparatus and instruments for biotechnology and life sciences, namely, data analyzers for collecting, storing and analyzing data in the fields of biology, drug discovery, healthcare, medicine and biotechnology, sequencers, microarrays, mass spectrometry equipment, namely, apparatus and instruments for mass spectrometry, microarray, DNA chip, biochemical arrays; laboratory equipment, namely, cell microarrays

Medical diagnostic testing, monitoring, analyzing and reporting services; medical diagnostics testing, monitoring, reporting services for the diagnosis of conditions of the human body; medical testing for diagnostic or treatment purposes; medical evaluation of cancer by determining the level and expression level of microRNAs in bodily fluid and tissue samples; health care services for treating cancer, respiratory infectious diseases, cardiovascular disease

Reagents for scientific and medical research use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; chemical reagents, namely, reagent strips for body fluid testing for use in the scientific research industry; chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical reagents, enzymes and buffer solutions for scientific and medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification, sequencing and analysis; kits comprising chemicals for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids or biological or biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification, sequencing and analysis; reagent kits comprising biological protein, DNA primers, polymerase or buffers for scientific and medical research; chemical, biochemical and biotechnological products for commercial and scientific use, namely, buffer solutions, nucleic acids, nucleic acid derivatives and proteins for chemical analysis

Medical diagnostic reagents; chemical reagents, namely, diagnostic medical reagent strips for use by individuals to test their own body fluids and for use by the medical profession; diagnostic biological reagents and chemical reagents for medical purposes; cartridges containing medical diagnostic reagents for use in blood analyzers, hematology analyzers, and analyzers for measuring, testing and analyzing body fluids; medical diagnostic assays for testing of bodily fluids and tissue in the detection, monitoring, and prediction of disease or other conditions, disease states, hormone level, drug level, drug response, organ function effectiveness, and clinical response; diagnostic preparations for medical purposes; diagnostic test kits comprised of medical diagnostic reagents and assays for testing in the field of medical diagnostics, namely, cancer, respiratory infectious diseases, cardiovascular disease; nucleic acid sequences and chemical reagents for medical purposes

Scientific research and development; science and technological services, namely, research in the field of medicine, medical and biological technologies; research and development in the field of biochemistry and biological technology; clinical diagnostic laboratory services; medical laboratory services; providing technical support services for laboratory equipment and systems, namely, troubleshooting in the nature of diagnosing problems with medical equipment; nucleic acid sequencing and analysis for medical and scientific research purposes; providing data for genomes, chromosomes, and proteins for medical and scientific research purposes; medical testing services for biomarkers diagnosis, treatment and observation for research purposes; consultation and research services in the field of gene analysis, life science study, human identification technique, microbial identification technique, and biotechnology; providing chemical screening analysis and medical research by using biological microarrays

Medical diagnostic instruments, namely, sample handlers in the nature of holder for clinical sample wells, tubes and vials, sample preparation equipment, equipment for obtaining and testing bodily fluids for medical diagnosis; blood analyzing instrument for medical diagnostic purposes and disposable cartridges and reagents for use therein; medical diagnostic apparatus for the analysis of body fluids used to detect and measure the level of substances in body fluids; clinical chemistry analyzers for medical diagnostic use in testing bodily fluids; blood analyzing instruments and systems for medical diagnostic purposes; medical diagnostic analyzers for measuring, testing and analyzing body fluids

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
May 28, 2025 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
May 28, 2025 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 26, 2025 APRE
TEAS SECTION 8 RECEIVED
Jan 15, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 5, 2024 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 6, 2019 ASGN
REGISTERED-PRINCIPAL REGISTER
Mar 5, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 30, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 29, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 28, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 28, 2019 AITU
USE AMENDMENT FILED
Jan 3, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 3, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 22, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jun 20, 2018 EX1G
SOU EXTENSION 1 FILED
Jun 20, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 20, 2018 EEXT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 19, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 19, 2018 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 16, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 21, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 21, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 1, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 19, 2017 PREV
ASSIGNED TO LIE
Oct 15, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 31, 2017 GNRN
NON-FINAL ACTION E-MAILED
May 31, 2017 GNRT
NON-FINAL ACTION WRITTEN
May 31, 2017 CNRT
ASSIGNED TO EXAMINER
May 25, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 9, 2017 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2017 NWOS
NEW APPLICATION ENTERED
Mar 6, 2017 NWAP